NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

糖尿病治療設備的全球市場:按產品進行的市場研究(血糖監測設備,胰島素輸送設備),分銷(離線模式,在線模式),預測(∼2025年),COVID-19的累積影響

Diabetes Care Devices Market Research Report by Product, by Distribution, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 998395
出版日期 內容資訊 英文 193 Pages
商品交期: 最快1-2個工作天內
價格
糖尿病治療設備的全球市場:按產品進行的市場研究(血糖監測設備,胰島素輸送設備),分銷(離線模式,在線模式),預測(∼2025年),COVID-19的累積影響 Diabetes Care Devices Market Research Report by Product, by Distribution, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 193 Pages
簡介

全球糖尿病治療設備市場預計將從2020年的1,584,690,000美元增長到2025年底的3,557,740,000美元。

市場細分和覆蓋範圍:

這份研究報告對糖尿病治療設備的全球市場進行了分類,預測了收入並分析了以下每個子市場的趨勢:

  • 通過產品,對糖尿病治療設備市場進行了跨血糖監測設備和胰島素輸送設備的調查。跨連續血糖監測儀,刺血針,自我監測血糖儀和試紙對血糖監測設備進行了進一步研究。使用胰島素噴射注射器,胰島素筆,胰島素泵和胰島素注射器進一步研究了胰島素輸送裝置。
  • 通過分銷,以離線和在線模式對糖尿病治療設備市場進行了調查。
  • 按地區,對美洲,亞太地區以及歐洲和中東/非洲的市場進行了調查。美洲是阿根廷,巴西,加拿大,墨西哥和美國。亞太地區是澳大利亞,中國,印度,印度尼西亞,日本,馬來西亞,菲律賓,韓國和泰國。在法國,德國,意大利,荷蘭,卡塔爾,俄羅斯,沙特阿拉伯,南非,西班牙,阿拉伯聯合酋長國和英國對歐洲以及中東和非洲地區進行了調查。

企業可用性配置文件:

報告包括Abbott Laboratories,Acon Laboratories,Inc.,AgaMatrix,Inc.,Arkray,Inc.,B.Braun Melsungen AG,Becton Dickinson and Company,Bionime,DexCom,Inc.,Diabeloop SA。,Echo Therapeutics,Inc. ,禮來公司(Eli Lilly and Company),霍夫曼拉羅氏(F.Hoffmann-La Roche AG),Glysens Incorporated,Insulet Corporation,Johnson&Johnson Services,Inc.,Medisana,Medtronic PLC,Nova Biomedical,Inc,Novo Nordisk A/S,PHC Holdings Corporation,Rossmax International We我們正在深入探索全球市場中領先的供應商(包括有限公司,賽諾菲公司,Sinocare公司,Terumo公司,Wockhardt有限公司和Ypsomed Holding AG)最近的重大發展和創新概況。

COVID-19的累積影響:

預計COVID-19將在預測期內對行業增長產生長期影響,因為這是無與倫比的全球公共衛生突發事件,幾乎影響了每個行業。我們正在進行的研究擴大了研究框架,以確保它包括潛在的COVID-19問題和潛在的未來路徑。該調查提供了有關COVID-19的見解,並考慮了消費者行為和需求,購買模式,供應鏈改路,當前市場勢力動態以及政府的主要干預措施的變化。更新後的調查提供了見解,分析,估計和預測,其中考慮了COVID-19對市場的影響。

本報告調查了糖尿病治療設備的全球市場,概述了市場,分析了市場增長和障礙,市場機會,COVID-19的影響以及按產品,分銷和地區劃分的市場規模變化。它提供系統信息,例如預測,競爭狀況和主要公司的概況。

360iResearch(TM)FPNV定位矩陣:

360iResearch(TM)FPNV定位矩陣提供業務戰略(業務增長,行業覆蓋範圍,財務可行性,渠道支持),以幫助公司做出更好的決策並瞭解其競爭格局,並根據產品滿意度對市場中的供應商進行評估和分類(性價比,易用性,產品功能和客戶支持)。

360iResearch(TM)競爭戰略窗口:

360iResearch(TM)競爭戰略窗口從市場,應用和區域角度分析競爭條件。這有助於供應商定義能力和機會之間的協調或適應,以實現未來的增長前景。在預測期內,供應商將採用持續的併購策略,區域擴展,研發和新產品實施策略,以最佳或有利地適應進一步的業務擴展和增長。

此報告提供有關以下準則的見解:

  • 1.市場滲透率:主要參與者提供的全面市場信息
  • 2.市場開發:有利可圖的新興市場的詳細信息和市場分析
  • 3.市場多元化:有關新產品發佈,欠發達地區,最新發展和投資的更多信息
  • 4.競爭評估和情報:全面評估主要公司的市場份額,戰略,產品和製造能力
  • 5.產品開發和創新:對未來技術,研發活動和新產品開發的智能見解

此報告回答以下問題

  • 1. 全球市場的規模和預測是多少?
  • 2. 在預測期內,COVID-19形成市場的障礙和影響是什麼?
  • 3. 在預測期內,您將投資哪些產品,細分,應用或領域?
  • 4. 市場機會的競爭性戰略窗口是什麼?
  • 5. 市場的技術趨勢和監管框架是什麼?
  • 6. 您認為適合進入市場的方式和戰略舉措是什麼?

目錄

第1章簡介

  • 調查目的
  • 市場細分和覆蓋範圍
  • 考慮調查的年份
  • 貨幣和價格
  • 語言
  • 限制
  • 利益相關者

第2章調查方法

  • 調查過程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:測量設備
    • 集合:數據源
    • 分析:數據解釋
    • 公式:數據驗證
    • 已發佈:調查報告
    • 重複:報告更新
  • 進行調查
    • 開始:調查過程
    • 計劃:創建調查計劃
    • 執行:進行調查
    • 驗證:發現和分析
    • 出版物:調查報告
  • 調查結果

第3章執行摘要

  • 市場前景
  • 產品展望
  • 分銷前景
  • 區域展望
  • 競爭對手展望

第4章市場概述

  • COVID-19的累積效果

第5章市場洞察

  • 市場動態
    • 促進因素
    • 抑製器
    • 市場機會
    • 挑戰
  • 搬運工五力分析
    • 新進入者的威脅
    • 替代威脅
    • 客戶的議價能力
    • 供應商的談判能力
    • 行業競爭

第6章按產品

  • 血糖監測裝置
    • 連續血糖監測儀
    • 柳葉刀
    • 自我監測血糖儀
    • 測試條
  • 胰島素輸送裝置
    • 胰島素噴射注射器
    • 胰島素筆
    • 胰島素泵
    • 胰島素注射器

第7章分發

  • 離線模式
  • 聯機模式

第8章美洲

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太

  • 澳大利亞
  • 中國
  • 印度
  • 印度尼西亞
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第10章歐洲,中東/非洲

  • 法國
  • 德國
  • 意大利
  • 荷蘭
  • 卡塔爾
  • 俄羅斯
  • 沙特阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合酋長國
  • 英國

第11章競爭情況

  • FPNV定位矩陣
    • 象限
    • 經營策略
    • 產品滿意度
  • 市場排名分析
  • 市場份額分析
  • 競爭性SWOT分析
  • 衝突情況
    • 併購
    • 協議,合作和夥伴關係
    • 推出和增強新產品
    • 投融資
    • 獎項,獎項,擴展

第12章企業可用性簡介

  • Abbott Laboratories
  • Acon Laboratories, Inc.
  • AgaMatrix, Inc.
  • Arkray, Inc.
  • B. Braun Melsungen AG
  • Becton, Dickinson, and Company
  • Bionime
  • DexCom, Inc.
  • Diabeloop SA.
  • Echo Therapeutics, Inc
  • Eli Lilly and Company
  • F.Hoffmann-La Roche AG
  • Glysens Incorporated
  • Insulet Corporation
  • Johnson & Johnson Services, Inc
  • Medisana
  • Medtronic PLC
  • Nova Biomedical, Inc
  • Novo Nordisk A/S
  • PHC Holdings Corporation
  • Rossmax International Ltd.
  • Sanofi S.A.
  • Sinocare, Inc.
  • Terumo Corporation
  • Wockhardt Limited
  • Ypsomed Holding AG

第13章附錄

  • 討論指南
  • 許可證和價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-43539E5D2EB0

The Global Diabetes Care Devices Market size was estimated at USD 1,584.69 Million in 2020 and expected to reach USD 1,870.82 Million in 2021, at a Compound Annual Growth Rate (CAGR) 18.39% to reach USD 4,364.54 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Diabetes Care Devices to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the Diabetes Care Devices Market was studied across Blood Glucose Monitoring Devices and Insulin Delivery Devices. The Blood Glucose Monitoring Devices is further studied across Continuous Glucose Monitors, Lancets, Self-Monitoring Blood Glucose Meters, and Testing Strips. The Insulin Delivery Devices is further studied across Insulin Jet Injectors, Insulin Pens, Insulin Pumps, and Insulin Syringes.

Based on Distribution, the Diabetes Care Devices Market was studied across Offline Mode and Online Mode.

Based on Geography, the Diabetes Care Devices Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Diabetes Care Devices Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Diabetes Care Devices Market, including Abbott Laboratories, Acon Laboratories, Inc., AgaMatrix, Inc., Arkray, Inc., B. Braun Melsungen AG, Becton, Dickinson, and Company, Bionime, DexCom, Inc., Diabeloop SA., Echo Therapeutics, Inc, Eli Lilly and Company, F.Hoffmann-La Roche AG, Glysens Incorporated, Insulet Corporation, Johnson & Johnson Services, Inc, Medisana, Medtronic PLC, Nova Biomedical, Inc, Novo Nordisk A/S, PHC Holdings Corporation, Rossmax International Ltd., Sanofi S.A., Sinocare, Inc., Terumo Corporation, Wockhardt Limited, and Ypsomed Holding AG.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Diabetes Care Devices Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Diabetes Care Devices Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Diabetes Care Devices Market?
  • 4. What is the competitive strategic window for opportunities in the Global Diabetes Care Devices Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Diabetes Care Devices Market?
  • 6. What is the market share of the leading vendors in the Global Diabetes Care Devices Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Diabetes Care Devices Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Product Outlook
  • 3.4. Distribution Outlook
  • 3.5. Geography Outlook
  • 3.6. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing diabetic population and rising awareness of diabetes treatment
      • 5.1.1.2. Rising need for new technologies such as glucose level monitoring
      • 5.1.1.3. Supportive government initiatives for diabetic care
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with advanced medical devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing trend of self care or home care
      • 5.1.3.2. Improved functionality with integration of advanced technologies
      • 5.1.3.3. Increasing mHealth applications
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of awareness and penetration in underdeveloped areas
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Diabetes Care Devices Market, by Product

  • 6.1. Introduction
  • 6.2. Blood Glucose Monitoring Devices
    • 6.2.1. Continuous Glucose Monitors
    • 6.2.2. Lancets
    • 6.2.3. Self-Monitoring Blood Glucose Meters
    • 6.2.4. Testing Strips
  • 6.3. Insulin Delivery Devices
    • 6.3.1. Insulin Jet Injectors
    • 6.3.2. Insulin Pens
    • 6.3.3. Insulin Pumps
    • 6.3.4. Insulin Syringes

7. Diabetes Care Devices Market, by Distribution

  • 7.1. Introduction
  • 7.2. Offline Mode
  • 7.3. Online Mode

8. Americas Diabetes Care Devices Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States
    • 8.6.1. California
    • 8.6.2. Florida
    • 8.6.3. Illinois
    • 8.6.4. New York
    • 8.6.5. Ohio
    • 8.6.6. Pennsylvania
    • 8.6.7. Texas

9. Asia-Pacific Diabetes Care Devices Market

  • 9.1. Introduction
  • 9.2. China
  • 9.3. India
  • 9.4. Indonesia
  • 9.5. Japan
  • 9.6. Malaysia
  • 9.7. Philippines
  • 9.8. South Korea
  • 9.9. Thailand

10. Europe, Middle East & Africa Diabetes Care Devices Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis, By Quadrant
  • 11.4. Market Share Analysis, By Company
  • 11.5. Competitive Scenario
    • 11.5.1. Merger & Acquisition
    • 11.5.2. Agreement, Collaboration, & Partnership
    • 11.5.3. New Product Launch & Enhancement
    • 11.5.4. Investment & Funding
    • 11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. Abbott Laboratories
  • 12.2. Acon Laboratories, Inc.
  • 12.3. AgaMatrix, Inc.
  • 12.4. Arkray, Inc.
  • 12.5. B. Braun Melsungen AG
  • 12.6. Becton, Dickinson, and Company
  • 12.7. Bionime
  • 12.8. DexCom, Inc.
  • 12.9. Diabeloop SA.
  • 12.10. Echo Therapeutics, Inc
  • 12.11. Eli Lilly and Company
  • 12.12. F.Hoffmann-La Roche AG
  • 12.13. Glysens Incorporated
  • 12.14. Insulet Corporation
  • 12.15. Johnson & Johnson Services, Inc
  • 12.16. Medisana
  • 12.17. Medtronic PLC
  • 12.18. Nova Biomedical, Inc
  • 12.19. Novo Nordisk A/S
  • 12.20. PHC Holdings Corporation
  • 12.21. Rossmax International Ltd.
  • 12.22. Sanofi S.A.
  • 12.23. Sinocare, Inc.
  • 12.24. Terumo Corporation
  • 12.25. Wockhardt Limited
  • 12.26. Ypsomed Holding AG

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing
  • 13.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL DIABETES CARE DEVICES MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL DIABETES CARE DEVICES MARKET: MARKET DYNAMICS
  • FIGURE 6. GLOBAL DIABETES CARE DEVICES MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 7. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
  • FIGURE 8. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
  • FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2026
  • FIGURE 10. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2026 (USD MILLION)
  • FIGURE 11. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 12. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORS, 2018-2026 (USD MILLION)
  • FIGURE 13. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 14. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY LANCETS, 2018-2026 (USD MILLION)
  • FIGURE 15. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY LANCETS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 16. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE METERS, 2018-2026 (USD MILLION)
  • FIGURE 17. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE METERS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 18. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY TESTING STRIPS, 2018-2026 (USD MILLION)
  • FIGURE 19. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY TESTING STRIPS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 20. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2026 (USD MILLION)
  • FIGURE 21. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 22. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN JET INJECTORS, 2018-2026 (USD MILLION)
  • FIGURE 23. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN JET INJECTORS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 24. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2026 (USD MILLION)
  • FIGURE 25. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 26. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2026 (USD MILLION)
  • FIGURE 27. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 28. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN SYRINGES, 2018-2026 (USD MILLION)
  • FIGURE 29. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN SYRINGES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 30. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2020 VS 2026 (%)
  • FIGURE 31. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2020 VS 2026 (USD MILLION)
  • FIGURE 32. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2026
  • FIGURE 33. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE MODE, 2018-2026 (USD MILLION)
  • FIGURE 34. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE MODE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 35. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY ONLINE MODE, 2018-2026 (USD MILLION)
  • FIGURE 36. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY ONLINE MODE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 37. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 38. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 39. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 40. ARGENTINA DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 41. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 42. CANADA DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 43. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 44. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 45. CALIFORNIA DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 46. FLORIDA DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 47. ILLINOIS DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 48. NEW YORK DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 49. OHIO DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 50. PENNSYLVANIA DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 51. TEXAS DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 52. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 53. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 54. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 55. CHINA DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 56. INDIA DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 57. INDONESIA DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 58. JAPAN DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 59. MALAYSIA DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 60. PHILIPPINES DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 61. SOUTH KOREA DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 62. THAILAND DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 63. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 64. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 65. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 66. FRANCE DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 67. GERMANY DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 68. ITALY DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 69. NETHERLANDS DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 70. QATAR DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 71. RUSSIA DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 72. SAUDI ARABIA DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 73. SOUTH AFRICA DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 74. SPAIN DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 75. UNITED ARAB EMIRATES DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 76. UNITED KINGDOM DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 77. GLOBAL DIABETES CARE DEVICES MARKET: FPNV POSITIONING MATRIX
  • FIGURE 78. GLOBAL DIABETES CARE DEVICES MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 79. GLOBAL DIABETES CARE DEVICES MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 80. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL DIABETES CARE DEVICES MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL DIABETES CARE DEVICES MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY LANCETS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE METERS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY TESTING STRIPS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN JET INJECTORS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN SYRINGES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE MODE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY ONLINE MODE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. ARGENTINA DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. ARGENTINA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. CANADA DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. CANADA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. CALIFORNIA DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. CALIFORNIA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. FLORIDA DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. FLORIDA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. ILLINOIS DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. ILLINOIS DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. NEW YORK DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. NEW YORK DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. OHIO DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. OHIO DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. PENNSYLVANIA DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. PENNSYLVANIA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. TEXAS DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. TEXAS DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. CHINA DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. CHINA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. INDIA DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. INDIA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. INDONESIA DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. INDONESIA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. JAPAN DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. JAPAN DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. MALAYSIA DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. MALAYSIA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. PHILIPPINES DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. PHILIPPINES DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. SOUTH KOREA DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. SOUTH KOREA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. THAILAND DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. THAILAND DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. FRANCE DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. FRANCE DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. GERMANY DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. GERMANY DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. ITALY DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. ITALY DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. NETHERLANDS DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. NETHERLANDS DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. QATAR DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. QATAR DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. RUSSIA DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. RUSSIA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. SAUDI ARABIA DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. SAUDI ARABIA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. SOUTH AFRICA DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. SOUTH AFRICA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. SPAIN DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. SPAIN DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 85. UNITED ARAB EMIRATES DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 86. UNITED ARAB EMIRATES DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 87. UNITED KINGDOM DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 88. UNITED KINGDOM DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 89. GLOBAL DIABETES CARE DEVICES MARKET: SCORES
  • TABLE 90. GLOBAL DIABETES CARE DEVICES MARKET: BUSINESS STRATEGY
  • TABLE 91. GLOBAL DIABETES CARE DEVICES MARKET: PRODUCT SATISFACTION
  • TABLE 92. GLOBAL DIABETES CARE DEVICES MARKET: RANKING
  • TABLE 93. GLOBAL DIABETES CARE DEVICES MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 94. GLOBAL DIABETES CARE DEVICES MARKET: SHARE, BY COMPANY, 2020
  • TABLE 95. GLOBAL DIABETES CARE DEVICES MARKET: MERGER & ACQUISITION
  • TABLE 96. GLOBAL DIABETES CARE DEVICES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 97. GLOBAL DIABETES CARE DEVICES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 98. GLOBAL DIABETES CARE DEVICES MARKET: INVESTMENT & FUNDING
  • TABLE 99. GLOBAL DIABETES CARE DEVICES MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 100. GLOBAL DIABETES CARE DEVICES MARKET: LICENSE & PRICING
  • TABLE 101. GLOBAL DIABETES CARE DEVICES MARKET: CONTACT DETAILS